Clinical trials of Japanese medicine for COVID-19 started in the USA
Hospitals in Massachusetts began the first US clinical trials of a Japanese drug for the treatment of coronavirus, writes Nbc boston.
Three hospitals in Massachusetts have received permission to conduct the first US clinical trial of a Japanese anti-flu drug that can be used to treat coronavirus infection COVID-19.
Trials of the drug, known as the Avigan brand name drug, will take place at the Massachusetts General Hospital, Brigham and Women's Hospital and the UMass Memorial Medical Center.
Doctors participating in the study say that the drug was widely used in treating people and that side effects are relatively well known.
The drug causes viruses to misread the genetic instructions and not reproduce properly, so the virus ends up "dissolving in vitro," said Dr. Robert Fienberg, an infectious disease specialist at UMass Memorial.
On the subject: In extreme cases: FDA approves anti-malarial medication for COVID-19
In the United States, between 50 and 60 patients, divided into two groups, will participate in clinical trials. The first group will receive the drug in addition to standard treatment, while the second group will receive only standard therapy.
Japan is currently conducting a similar clinical trial to evaluate the safety of the drug.
The Trump administration is putting pressure on the FDA to approve the drug as a treatment for COVID-19, but there are still concerns about the risks and limited evidence that the drug is effective.
Read also on ForumDaily:
Symptom Relief Exercises: Joan Rowling Talks About Her Fight Against Coronavirus
'Don't come near me!': How Americans comply with quarantine requirements
5G and coronavirus: a new conspiracy theory causes panic and looting
Subscribe to ForumDaily on Google NewsDo you want more important and interesting news about life in the USA and immigration to America? — support us donate! Also subscribe to our page Facebook. Select the “Priority in display” option and read us first. Also, don't forget to subscribe to our РєР ° РЅР ° Р »РІ Telegram and Instagram- there is a lot of interesting things there. And join thousands of readers ForumDaily New York — there you will find a lot of interesting and positive information about life in the metropolis.